[go: up one dir, main page]

IN2014MN01555A - - Google Patents

Info

Publication number
IN2014MN01555A
IN2014MN01555A IN1555MUN2014A IN2014MN01555A IN 2014MN01555 A IN2014MN01555 A IN 2014MN01555A IN 1555MUN2014 A IN1555MUN2014 A IN 1555MUN2014A IN 2014MN01555 A IN2014MN01555 A IN 2014MN01555A
Authority
IN
India
Prior art keywords
ophthalmic composition
ophthalmic
container
geranylgeranylacetone
kit
Prior art date
Application number
Inventor
MIYANOTakayuki
KUROSETakahiro
Original Assignee
Rohto Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rohto Pharma filed Critical Rohto Pharma
Publication of IN2014MN01555A publication Critical patent/IN2014MN01555A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/121—Ketones acyclic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/12—Non-macromolecular oxygen-containing compounds, e.g. hydrogen peroxide or ozone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D65/00—Wrappers or flexible covers; Packaging materials of special type or form
    • B65D65/38—Packaging materials of special type or form
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
    • Y10T428/1352—Polymer or resin containing [i.e., natural or synthetic]
    • Y10T428/1397—Single layer [continuous layer]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Mechanical Engineering (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Physiology (AREA)

Abstract

An ophthalmic composition kit in which an ophthalmic composition containing a geranylgeranylacetone is stored in an ophthalmic container wherein at least a portion of or the entire surface of the ophthalmic container that comes into contact with the ophthalmic composition is configured from a container material selected from among a polyolefin an acrylic acid resin a terephthalic acid ester a polycarbonate a polymethyl terpene a fluorine resin or glass. In said ophthalmic composition kit the decline in the content or concentration of the geranylgeranylacetone within the ophthalmic composition is extremely small.
IN1555MUN2014 2012-02-27 2013-02-25 IN2014MN01555A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012040548 2012-02-27
PCT/JP2013/054780 WO2013129318A1 (en) 2012-02-27 2013-02-25 Ophthalmic composition kit

Publications (1)

Publication Number Publication Date
IN2014MN01555A true IN2014MN01555A (en) 2015-07-03

Family

ID=49082515

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1555MUN2014 IN2014MN01555A (en) 2012-02-27 2013-02-25

Country Status (7)

Country Link
US (3) US20130331458A1 (en)
JP (3) JP5345743B1 (en)
CN (1) CN104136019A (en)
HK (1) HK1200110A1 (en)
IN (1) IN2014MN01555A (en)
TW (1) TW201340960A (en)
WO (1) WO2013129318A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2922919B1 (en) 2012-11-21 2020-03-25 University Of Louisville Research Foundation, Inc. Compositions and methods for reducing oxidative damage
JP5687395B2 (en) * 2013-02-19 2015-03-18 ロート製薬株式会社 Mucosal application agent for prevention, improvement, or treatment of retinal diseases
JP5483513B1 (en) * 2013-02-19 2014-05-07 ロート製薬株式会社 Mucosal application agent for prevention, improvement, or treatment of retinal diseases
UA121746C2 (en) * 2014-01-10 2020-07-27 Сантен Фармасутікал Ко., Лтд. PHARMACEUTICAL COMPOSITION CONTAINING A PYRIDYLAMINOACETIC ACID COMPOUND
CA3014030C (en) 2015-02-09 2023-10-03 Ori Braun Ophthalmic compositions and methods for reducing oxidative damage to an eye lens
UA123004C2 (en) * 2015-02-27 2021-02-03 Анхесер-Бюш Інбев С.А. Appliances and containers for preparing a beverage in a transparent chamber
WO2017183714A1 (en) 2016-04-22 2017-10-26 ロート製薬株式会社 Ophthalmic composition
CN109069421B (en) * 2016-04-22 2021-10-12 乐敦制药株式会社 Ophthalmic composition
TWI828025B (en) * 2016-08-23 2024-01-01 日商大塚製藥股份有限公司 Ophthalmic pharmaceutical composition with improved preservative effectiveness or light stability
CN113692305A (en) * 2019-04-26 2021-11-23 参天制药株式会社 Ophthalmic product and use thereof
US20220228066A1 (en) * 2019-05-02 2022-07-21 International Suppliers And Contractors Inc. A Method for the Preparation of a Stable, Fire-Retardant Composition of Boron-Containing Compounds, the Composition so Obtained and a Method and a Use of Said Composition
WO2021079405A1 (en) 2019-10-21 2021-04-29 ロート製薬株式会社 Resin container and linked resin container article
US12295910B2 (en) 2019-10-21 2025-05-13 Rohto Pharmaceutical Co., Ltd. Resin container and resin container connected body
JP7053966B2 (en) * 2020-03-31 2022-04-12 参天製薬株式会社 A silver salt-containing aqueous composition for ophthalmology filled in a resin container
WO2022050295A1 (en) * 2020-09-01 2022-03-10 ロート製薬株式会社 Composition for external use on skin

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0448189Y2 (en) * 1988-02-26 1992-11-13
JP3256997B2 (en) * 1990-08-30 2002-02-18 千寿製薬株式会社 Stable aqueous formulation
NO950970L (en) * 1994-03-15 1995-09-18 Senju Pharma Co Method of Stabilizing Pranoprofen and Stable Liquid Preparations of Pranoprofen
JPH08133967A (en) * 1994-11-02 1996-05-28 Eisai Co Ltd Agent for treating dry eye
JPH08266587A (en) * 1995-03-30 1996-10-15 Taisho Pharmaceut Co Ltd Eye drop container
JPH10295777A (en) * 1997-04-28 1998-11-10 Taisho Pharmaceut Co Ltd Stable antibacterial eye drops
JP2000319170A (en) * 1999-03-05 2000-11-21 Eisai Co Ltd Teprenone-containing eye lotion
JP2005247803A (en) * 2004-03-08 2005-09-15 Zeria Pharmaceut Co Ltd Eye drops and their containers
JP2008189632A (en) * 2007-02-08 2008-08-21 Teika Seiyaku Kk Ophthalmic preparation
US9456980B2 (en) * 2007-08-29 2016-10-04 Wakamoto Pharmaceutical Co., Ltd. Latanoprost-containing aqueous pharmaceutical composition
CA2749352A1 (en) * 2009-02-20 2010-09-10 Micro Labs Limited Storage stable prostaglandin product

Also Published As

Publication number Publication date
US20160089345A1 (en) 2016-03-31
JP2013213052A (en) 2013-10-17
JP5483512B2 (en) 2014-05-07
WO2013129318A1 (en) 2013-09-06
CN104136019A (en) 2014-11-05
US20140045948A1 (en) 2014-02-13
TW201340960A (en) 2013-10-16
JP2013213053A (en) 2013-10-17
JPWO2013129318A1 (en) 2015-07-30
JP5345743B1 (en) 2013-11-20
US20130331458A1 (en) 2013-12-12
HK1200110A1 (en) 2015-07-31

Similar Documents

Publication Publication Date Title
IN2014MN01555A (en)
AR084770A1 (en) OXYGEN ABSORPTION AND CARBON DIOXIDE IN A SINGLE-USE CONTAINER WITH AN ABSORBENT SUPPORT BELOW THE FILTER
GB2495379B (en) Transmission guide
MX2012013530A (en) LID AND DISTRIBUTION SYSTEM FOR A PORTABLE CONTAINER.
WO2012064071A3 (en) Adhesive composition
EP2703710A4 (en) POLYCARBONATE RESIN COMPOSITION FOR TRANSPARENT BODY, TRANSPARENT BODY, AND LUMINOUS SURFACE SOURCE COMPRISING THE SAME
IN2014MN01553A (en)
AU340703S (en) Wake up light
WO2012104704A3 (en) Illuminated electrical enclosure lid
IL238019A0 (en) Reactor with light emitting particles in the reaction medium
IN2014MN01554A (en)
AU331805S (en) Dispenser
MY166053A (en) Tablet containing limaprost and ß-cyclodextrin
IN2014KN01697A (en)
WO2013060672A3 (en) A cooling device comprising a storage tank wherein the liquid stored therein is sterilized
AU334752S (en) Container with lid
PH12017500083B1 (en) Infant formula container with compartment and lid
TWD145197S1 (en) Liquid tank
CO6750131U1 (en) Pinata dish
HN2008000115A (en) ABSOLUT VODKA BOTTLE DESIGN UNDER CUBT IERTA
DOP2011000275A (en) LIQUID CLEANING COMPOSITION WITH FILMS
AU334945S (en) Container_c - coffee vessel
AU343598S (en) Display stand
AU337609S (en) Candy circular light
RU2012147467A (en) DRINKING GLASS